LLY

1,007.5

-0.79%↓

JNJ

230.78

+0.16%↑

ABBV

210.82

+1.12%↑

UNH

398.96

-0.39%↓

AZN

184.93

-1.48%↓

LLY

1,007.5

-0.79%↓

JNJ

230.78

+0.16%↑

ABBV

210.82

+1.12%↑

UNH

398.96

-0.39%↓

AZN

184.93

-1.48%↓

LLY

1,007.5

-0.79%↓

JNJ

230.78

+0.16%↑

ABBV

210.82

+1.12%↑

UNH

398.96

-0.39%↓

AZN

184.93

-1.48%↓

LLY

1,007.5

-0.79%↓

JNJ

230.78

+0.16%↑

ABBV

210.82

+1.12%↑

UNH

398.96

-0.39%↓

AZN

184.93

-1.48%↓

LLY

1,007.5

-0.79%↓

JNJ

230.78

+0.16%↑

ABBV

210.82

+1.12%↑

UNH

398.96

-0.39%↓

AZN

184.93

-1.48%↓

Home・Aktien・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Geschlossen

BrancheGesundheitswesen

536.66 3.9

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

515.98

Max

545.35

Schlüsselkennzahlen
By Trading Economics
Einkommen	-36M -94M
Verkäufe	-9.7M 311M
EPS	-1.38
Gewinnspanne	-30.318
Angestellte	915
EBITDA	-43M -93M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+29.95% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	4. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-499M 11B
Vorheriger Eröffnungskurs	532.76
Vorheriger Schlusskurs	536.66

Nachrichtenstimmung

By Acuity

34%

66%

96 / 346 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

263.2 / 277.1 Unterstützung & Widerstand

Madrigal Pharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Mai 2026, 22:44 UTC

Akquisitionen, Fusionen, Übernahmen

LVMH to Sell Marc Jacobs Fashion Brand to WHP, G-III Apparel -- 2nd Update

14. Mai 2026, 22:27 UTC

Akquisitionen, Fusionen, Übernahmen

LVMH Selling Marc Jacobs Fashion Brand to WHP, G-III Apparel -- Update

14. Mai 2026, 22:12 UTC

Ergebnisse

Applied Materials Raises Outlook as Semiconductor Equipment Demand Grows -- 2nd Update

14. Mai 2026, 21:52 UTC

Akquisitionen, Fusionen, Übernahmen

LVMH to Sell Marc Jacobs

15. Mai 2026, 00:00 UTC

Ergebnisse

Honda's Never Faced a Crisis Like This -- And a Comeback Won't Be Easy -- WSJ

14. Mai 2026, 23:57 UTC

Akquisitionen, Fusionen, Übernahmen

Kakao: Stake Sales Aim to Secure Funds for Future Investments

14. Mai 2026, 23:56 UTC

Akquisitionen, Fusionen, Übernahmen

Kakao: Share Sale to Lower Kakao Investment's Stake in Dunmau to 4.03%

14. Mai 2026, 23:56 UTC

Akquisitionen, Fusionen, Übernahmen

Kakao: Affiliate Kakao Investment to Sell 2.3M Dunamu Shares on June 15

14. Mai 2026, 23:56 UTC

Market Talk

Gold Prices Rise on Strong Demand -- Market Talk

14. Mai 2026, 23:56 UTC

Akquisitionen, Fusionen, Übernahmen

Kakao to Sell 6.55% Stake in Crypto Exchange Operator Dunamu to Hana Financial for KRW1.003T

14. Mai 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

14. Mai 2026, 23:50 UTC

Market Talk

Nikkei May Rise as AI Enthusiasm Continues -- Market Talk

14. Mai 2026, 23:47 UTC

Ergebnisse

JSW Steel: Prolonged Supply-Chain Disruptions Due to Middle East Crisis Pose Risk to Growth >500228.BY

14. Mai 2026, 23:47 UTC

Ergebnisse

JSW Steel Results Supported by Higher Steel Prices, One-Off Divestment Gains >500228.BY

14. Mai 2026, 23:46 UTC

Ergebnisse

JSW Steel 4Q Net INR163.7B Vs. Net INR21.39B >500228.BY

14. Mai 2026, 23:46 UTC

Ergebnisse

JSW Steel 4Q Rev INR511.8B Vs. INR448.19B >500228.BY

14. Mai 2026, 23:28 UTC

Market Talk

New Zealand's Economy Faltering Amid Shocks -- Market Talk

14. Mai 2026, 23:00 UTC

Market Talk

Australia's One Nation Party Leads In The Polls -- Market Talk

14. Mai 2026, 22:46 UTC

Market Talk

Global Equities Roundup: Market Talk

14. Mai 2026, 22:46 UTC

Market Talk

Court Decision 'Negative But Balanced' for Coles -- Market Talk

14. Mai 2026, 22:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14. Mai 2026, 22:35 UTC

Market Talk

Fed's Warsh Talks Big Game; Will Focus On Credibility First -- Market Talk

14. Mai 2026, 22:11 UTC

Akquisitionen, Fusionen, Übernahmen

LVMH Agrees to Sell Marc Jacobs -- WSJ

14. Mai 2026, 22:06 UTC

Market Talk

Applied Materials Gets Improved Visibility into Customer Orders -- Market Talk

14. Mai 2026, 22:04 UTC

Ergebnisse

Thai Beverage Results Supported by Higher Contributions From Spritis Business >Y92.SG

14. Mai 2026, 22:04 UTC

Ergebnisse

Thai Beverage 2Q Net THB7.37B Vs. Net THB6.74B >Y92.SG

14. Mai 2026, 22:04 UTC

Ergebnisse

Thai Beverage 2Q Rev THB86.52B Vs. THB85.35B >Y92.SG

14. Mai 2026, 22:00 UTC

Ergebnisse

Xanadu Quantum Revenue Increases Fourfold. Why the Stock Is Falling. -- Barrons.com

14. Mai 2026, 21:55 UTC

Ergebnisse

Nu Holdings 1Q EPS 18c >NU

14. Mai 2026, 21:55 UTC

Ergebnisse

Nu Holdings 1Q Rev $4.97B >NU

Peer-Vergleich

Kursveränderung

Madrigal Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

29.95% Vorteil

12-Monats-Prognose

Durchschnitt 674.25 USD 29.95%

Hoch 964 USD

Tief 550 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Madrigal Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

Buy

Halten

Sell

Basierend auf 8 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Madrigal Pharmaceuticals Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

263.2 / 277.1Unterstützung & Widerstand

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Stimmung

By Acuity

96 / 346 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.